Name |
Components |
Example of uses, and other notes
|
ABVD
|
Adriamycin, bleomycin, vinblastine, dacarbazine
|
Hodgkin's lymphoma
|
AC
|
Adriamycin/Doxorubicin, Cyclophosphamide
|
Breast cancer
|
BEACOPP
|
Bleomycin, etoposide, Adriamycin (doxorubicin), cyclophosphamide, Oncovin (vincristine), procarbazine, prednisone
|
Hodgkin's lymphoma
|
BEP
|
Bleomycin, etoposide, platinum (cisplatin)
|
Testicular cancer, germ cell tumors
|
CAF
|
Cyclophosphamide, Adriamycin/Doxorubicin, 5-FU/Fluorouracil
|
Breast cancer
|
CAV
|
Cyclophosphamide, Adriamycin/Doxorubicin, Vincristine
|
Lung cancer
|
CHOP
|
Cyclophosphamide, doxorubicin (hydroxydoxorubicin), vincristine (Oncovin), prednisone
|
Non-Hodgkin lymphoma
|
CHOP-R
|
CHOP + rituximab
|
B cell non-Hodgkin lymphoma
|
COP or CVP
|
Cyclophosphamide, vincristine (Oncovin), and prednisone
|
Non-Hodgkin lymphoma in patients with history of cardiovascular disease
|
CMF
|
Cyclophosphamide, Methotrexate, and 5-Fluorouracil
|
Breast Cancer
|
COPP
|
Cyclophosphamide, Oncovin (vincristine), procarbazine and prednisone
|
Non-Hodgkin lymphoma
|
DA-EPOCH [1]
|
Dose-adjusted Etopiside, prednisone, vincristine (Oncovin), Cyclophosphamide and doxorubicin
|
Newly diagnosed, aggressive non-Hodgkin lymphoma
|
DHAP
|
Dexamethasone, cytarabine (high-dose ARA-C), cisplatin
|
Recurrent or refractory non-Hodgkin lymphoma
|
EC
|
Epirubicin, Cyclophosphamide
|
Breast cancer
|
ECF
|
Epirubicin, cisplatin, fluorouracil
|
Gastric cancer and oesophageal cancer
|
ESHAP
|
Etopiside, methylprednisolone (Solu-medrol), cytarabine (ARA-C), cisplatin
|
Relapsed or refractory non-Hodgkin lymphoma
|
FN-D
|
Fludarabine, mitoxantrone (Novantrone), dexamethasone
|
Recurrent or refractory indolent non-Hodgkin lymphoma
|
FOLFOX
|
Fluorouracil, leucovorin (folinic acid), and oxaliplatin
|
Colorectal cancer
|
HYPER-CVAD
|
Hyperfractionated cyclophosphamide, vincristine (Oncovin), doxorubicin (Adriamycin), dexamethasone (Decadron)
|
Burkitt's lymphoma
|
ICE
|
Ifosfamide, carboplatin, etopiside
|
Relapsed or primary refractory non-Hodgkin lymphoma
|
ICE-R
|
ICE + rituximab
|
Relapsed or primary refractory non-Hodgkin lymphoma
|
m-BACOD
|
Methotrexate, bleomycin, doxorubicin (Adriamycin), cyclophosphamide, vincristine (Oncovin), dexamethasone (Decadron)
|
Non-Hodgkin lymphoma
|
MACOP-B
|
Methotrexate, leucovorin, doxorubicin (Adriamycin), cyclophosphamide, vincristine (Oncovin), prednisone, bleomycin
|
Non-Hodgkin lymphoma
|
MOPP
|
Mechlorethamine, vincristine (oncovin), procarbazine, prednisone
|
Hodgkin's lymphoma
|
PCV
|
Procarbazine, lomustine (CCNU), vincristine
|
Brain tumors
|
ProMACE-MOPP
|
Methotrexate, doxorubicin (Adriamycin), cyclophosphamide, etoposide + MOPP
|
Non-Hodgkin lymphoma
|
ProMACE-CytaBOM
|
Prednisone, doxorubicin (adriamycin), cyclophosphamide, etoposide, cytarabine, bleomycin, vincristine (Oncovin), methotrexate, leucovorin
|
Non-Hodgkin lymphoma
|
R-FCM
|
Rituximab, fludarabine, cyclophosphamide, mitoxantrone
|
B cell non-Hodgkin lymphoma
|
Stanford V
|
Doxorubicin (Adriamycin), mechlorethamine, bleomycin, vinblastine, vincristine (Oncovin), etoposide (VP-16), prednisone
|
Hodgkin's lymphoma
|
Thal/Dex
|
Thalidomide, dexamethasone
|
Multiple myeloma
|
VAD
|
Vincristine, Adriamycin (doxorubicin), dexamethasone
|
Multiple myeloma
|